Home | Donate | Print Page | Contact Us | Sign In | Join
News & Press: NYS DOH

Opportunity to Increase Access to Buprenorphine

Wednesday, July 26, 2017  
Share |

The New York State Department of Health AIDS Institute (NYSDOH AI) is pleased to introduce you to the NYSDOH Buprenorphine Access Initiative. The goal of the Initiative is to increase the number of certified health care practitioners prescribing buprenorphine and improve patient access to buprenorphine within a variety of settings.

Our aim is to better understand the availability of buprenorphine providers throughout the state so we can target our efforts to increase the number of providers where there is greatest need and support existing providers in expanding their scope of services.

Enclosed with this message is a link to a 5-minute online survey. All results of this survey are for internal use by NYSDOH AI only and will not be displayed on any public directory. https://www.surveymonkey.com/r/surveyNYSproviders

If you have any questions about the Initiative, would like to invite others to join, please contact buprenorphine@health.ny.gov or 1.800.692.8528.

This is an Advisory from the New York State Department of Health. This Advisory can be viewed from the link below:


For questions: Please send an e-mail to buprenorphine@health.ny.gov, as notify01 is a non-monitored mailbox.

Office Hours: M-F 8:30am - 5:00pm | Tel: 518-348-0719 | Fax: 518-348-0720 | Email: info@TheNPA.org